3-D MATRIX EUROPE SAS

3-D Matrix Europe is manufacturer of medical devices based on self-assembling peptides (SAP), a uniquely innovative platform technology. SAP form hydrogels with various applications in surgery (PuraStat(R) a hemostatic agent), in tissue regeneration, and in drug delivery.

3-D Matrix has driven development of its technology using a “lean company” model, leveraging the activities of its founding scientists at MIT, the company’s multiple collaborations with leading companies, outsourced manufacturing to contract facilities, and distribution agreements for its commercial products. 3-D Matrix's products are sold today mainly in Europe, Japan, United States, Australia.

3-D Matrix Europe is a wholly owned subsidiary of 3-D Matrix Ltd, Tokyo, Japan, a public company listed on the JASDAQ.